Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000899243-23-001524

Co-Chief Executive Officer sold 5,968 shares at an average $36.30 ($216,629)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Joshua B Co-Chief Executive Officer 2023-01-06 Sale +4,122 $36.08 $148,717 2,894,463 D
Cohen Joshua B Co-Chief Executive Officer 2023-01-06 Sale +1,846 $36.79 $67,912 2,892,617 D
Open-market sales · 5,968 sh · avg $36.30 · $216,629
Loading xslF345X03/doc4.xml…